Current treatment practices and efficacy in solar urticaria: insights from a patient survey
SolU is generally perceived as severe by affected patients, leading to a high impairment of quality of life. Performed therapies, including off-label treatments, are not sufficient to reach complete remission of symptoms in the majority of patients. Effective therapeutics for SolU are urgently needed to achieve better care for this highly burdened patient population.
Authors
- Margarida Gonçalo (ORCID: https://orcid.org/0000-0001-6842-1360)
- Dorothea Terhorst‐Molawi (ORCID: https://orcid.org/0000-0001-9411-8998)
- Heike Röckmann (ORCID: https://orcid.org/0000-0002-8565-2619)
- Lesley Elizabeth Rhodes (ORCID: https://orcid.org/0000-0002-9107-6654)
- Kanokvalai Kulthanan (ORCID: https://orcid.org/0000-0002-7618-821X)
- Lea Kiefer (ORCID: https://orcid.org/0000-0003-2882-4784)
- Ana Maria Giménez‐Arnau (ORCID: https://orcid.org/0000-0001-5434-7753)
- Emek Kocatürk (ORCID: https://orcid.org/0000-0003-2801-0959)
- Karsten Weller (ORCID: https://orcid.org/0000-0003-4437-0313)
- Sheila M. McSweeney (ORCID: https://orcid.org/0000-0001-7977-6028)
- Felix Aulenbacher
- Atsushi Fukunaga (ORCID: https://orcid.org/0009-0002-0142-270X)
- Manuel P. Pereira
Institutions
- Guy's Hospital (GB)
- Siriraj Hospital (TH)
- Koç University (TR)
- Universitat Pompeu Fabra (ES)
- Manchester Academic Health Science Centre (GB)
- Salford Royal NHS Foundation Trust (GB)
- University Medical Center Utrecht (NL)
- Humboldt-Universität zu Berlin (DE)
- Fraunhofer Institute for Translational Medicine and Pharmacology (DE)
- St John's Hospital (GB)
- Hospital del Mar Research Institute (ES)
- Kobe University (JP)
- University of Coimbra (PT)
Publication Details
- Journal
- Frontiers in Immunology
- Published
- 2025-11-04
- DOI
- https://doi.org/10.3389/fimmu.2025.1683524
- Citations
- 1
- Primary Topic
- Urticaria and Related Conditions
- Type
- article
- Field-Weighted Citation Impact
- 1.67